Neurocrine Biosciences
NBIX
#1206
Rank
โ‚ฌ14.85 B
Marketcap
146,70ย โ‚ฌ
Share price
1.52%
Change (1 day)
11.76%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): โ‚ฌ0.59 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are โ‚ฌ2.24 Billion. In 2023 the company made an earning of โ‚ฌ0.34 Billion, an increase over its 2022 earnings that were of โ‚ฌ0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ0.59 B73.6%
2023 โ‚ฌ0.34 B62.85%
2022 โ‚ฌ0.21 B73.74%
2021 โ‚ฌ0.12 B-8.82%
2020 โ‚ฌ0.13 B77.78%
2019 โ‚ฌ75.25 M49.83%
2018 โ‚ฌ50.22 M-142.57%
2017 -โ‚ฌ0.12 Billion-14.73%
2016 -โ‚ฌ0.14 Billion53.15%
2015 -โ‚ฌ90.34 Million46.25%
2014 -โ‚ฌ61.78 Million29.66%
2013 -โ‚ฌ47.65 Million-3530.8%
2012 โ‚ฌ1.38 M-95.73%
2011 โ‚ฌ32.53 M
2009 -โ‚ฌ45.74 Million-45.38%
2008 -โ‚ฌ83.72 Million-58.87%
2007 -โ‚ฌ0.21 Billion87.3%
2006 -โ‚ฌ0.11 Billion351.97%
2005 -โ‚ฌ24.05 Million-52.09%
2004 -โ‚ฌ50.19 Million-10.98%
2003 -โ‚ฌ56.38 Million
2001 -โ‚ฌ42.09 Million
1999 -โ‚ฌ18.98 Million108.32%
1998 -โ‚ฌ9.12 Million
1996 โ‚ฌ2.78 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ18.43 M-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.84 B 192.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚ฌ31.02 Million-104.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.73 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.90 B 995.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.65 B 957.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.2 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ40.05 Million-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA